close

Enter

Log in using OpenID

Hemophilia Gene Therapy Market : Get Facts About Business Strategies 2018–2026 Hemophilia Gene Therapy Market Demand To Escalate Till 2026

embed
Hemophilia is a genetic bleeding disorder in which an individual lacks or has low levels of proteins called clotting factors. There are around 13 types of clotting factors that work with blood platelets, which are necessary for clotting process to i
Hemophilia Gene Therapy Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2018-2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Hemophilia Gene Therapy Market – Overview
Hemophilia is a genetic disorder in which patient’s blood do not clot normally due to lack of blood-clotting proteins
known as coagulating factors. Conventional treatment options include timely replacement of the specific clotting factor.
Major pharma and biotech companies are conducting research and development to develop gene therapy for hemophilia
due to various shortcomings with conventional therapy. Increasing number of hemophilic patients that require treatment
and strong product pipeline are expected to drive growth of the hemophilia gene therapy market.
Major factors that are driving growth of the hemophilia gene therapy market include increasing prevalence of
hemophilia, issue of high cost, access to current hemophilia treatment, which includes coagulation factor VIII and IX,
and increasing number of companies engaged in research and development of gene therapy products. According to the
Centers for Disease Control and Prevention, hemophilia A is a rare, X-linked bleeding disorder that affects around 1 in
5,000 to 10,000 live-born males. Hemophilia B is less common than hemophilia A, with an incidence of around 1 in
25,000 births.
High prevalence of hemophilia is increasing demand for sustainable treatment of the disease, which is projected to drive
the market growth over the forecast period. According to the National Hemophilia Foundation factsheet 2018,
hemophilia affected over 400,000 individuals worldwide. Moreover, according to same source, an estimated 75% of
patients suffering from hemophilia have no access to treatment or receive inadequate treatment.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Hemophilia Gene Therapy Market Taxonomy:
By Type:
●
Hemophilia A
●
Hemophilia B
By Region:
●
North America
●
Latin America
●
Europe
●
Asia Pacific
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2480
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Hemophilia Gene Therapy Market: Key Players
●
BioMarin Pharmaceuticals, Inc.
●
Spark Therapeutics.
●
Pfizer, Inc.
●
UniQure NV
●
Ultragenyx Pharmaceutical
●
Shire PLC
●
Sangamo Therapeutics
●
Freeline Therapeutics
View this report @
https://www.coherentmarketinsights.com/market-insight/hemophilia-gene-therapy-market-2480
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization
focused on assisting its plethora of clients achieve transformational growth by helping
them make critical business decisions. We are headquartered in India, with an office at
the global financial capital in the U.S. Our client base includes players from across all
business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various
recommendations about operational improvements, technologies, emerging market
trends and new working methods. We offer both customized and syndicated market
research reports that help our clients create visionary growth plans to provide traction to
their business. We meticulously study emerging trends across various industries at both
the global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARC
H
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our
clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained
growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
To k no w mor e abo ut us , v is it o ur w eb site:
w ww.coh er en tmark etins ig hts.com
THANK YOU
© Coherent market Insights. All Rights Reserved
F or s ales q ueries o r new top ics email u s o n :
s [email protected] er en tmark etins ig hts .co m
Fo r o th er q uer ies co n tact:
Mr. Sh ah
( Man ag er - Bus iness D ev elo pment)
Co herent Mark et Ins ig hts
s [email protected] er en tmark etins ig hts .co m
+1 -2 06 -7 0 1- 67 02
Author
Maddy S
Maddy S81   document Email
Document
Category
Business and Leadership
Views
9
File Size
387 KB
Tags
hemophilia, revenue, growth
1/--pages
Report inappropriate content